KRC-00715

CAT: 0931-T200380-01Size: 25 mgDry Ice: NoHazardous: No
CAT#:0931-T200380-01Size:25 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2079853-72-6
Target
C-Met/HGFR
Related Pathways
Tyrosine Kinase/Adaptors
Bioactivity
KRC-00715 is an orally effective inhibitor of c-Met, exhibiting high selectivity with an IC50 of 9.0 nM. This compound specifically inhibits the growth of gastric cancer cell lines with high c-Met expression by inducing G1/S phase block, and reduces the activity of downstream signals, including Akt, Erk, and c-Met itself. In the gastric cancer cell line Hs746T, KRC-00715 demonstrates cytotoxicity with an IC50 of 39 nM and selectively inhibits the proliferation of cell lines that overexpress c-Met. Additionally, KRC-00715 decreases tumor size in Hs746T xenograft mouse models.
Smiles
FC(F)(F)C=1C=C(C=CC1OCCN2CCOCC2)C3=NC4=C(N=NN4CC5OC6=CC=CN=C6NC5)N=C3
Molecular Formula
C25H25F3N8O3
Molecular Weight
542.51
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T71382-01KRC-108
T69900-01GUN 00775
T130472-01Compound NP-007105
T130463-01Compound NP-007157
T130485-01Compound NP-007015
T130422-01Compound NP-007415
T131183-01Compound N069-0075
T131187-01Compound N069-0071
T27740-01KRCA-0377
T2641-01KRCA-0008

Alternative Products

CatalogName
HY-164411KRC-00715
MBS5813920KRC-108

Popular Products